首页> 外文期刊>Nephron >Renal clearance of N(1)-methylnicotinamide: a sensitive marker of the severity of liver dysfunction in cirrhosis.
【24h】

Renal clearance of N(1)-methylnicotinamide: a sensitive marker of the severity of liver dysfunction in cirrhosis.

机译:N(1)-甲基烟酰胺的肾清除率:肝硬化肝功能障碍严重程度的敏感标志物。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND/AIMS: Data have appeared suggesting that an impairment of renal tubular secretion is present in liver cirrhosis, even in the absence of a clinically evident renal dysfunction. To address this question, we evaluated the renal clearance of N(1)-methylnicotinamide (NMN), a marker of the renal secretory function, in healthy subjects and patients with liver cirrhosis of increasing severity, but with a normal glomerular filtration rate. METHODS: The renal clearances of endogenous NMN, inulin, and creatinine were measured in 14 normal subjects and in two groups of age-matched cirrhotic patients (10 Child A and 10 Child C). In 6 subjects, 2 per group, the concentration dependence of the NMN clearance was also studied, following an oral nicotinamide load. RESULTS: Contrary to expectations, the renal NMN clearance increased in cirrhotic patients, in relation to the severity of liver disease (r = 0.83 with Pugh's score; p < 0.001). The NMN-to-inulin clearance ratio increased from a control value of 2.2 +/- (SD) 0.4 to 3.1 +/- 0.2 and 5.2 +/- 0.9 in Child A and Child C cirrhotics, respectively (p < 0.001 for all comparisons), indicating that NMN was completely cleared from plasma in the latter patients. Consistently, the analysis of the concentration dependence of the renal NMN clearance revealed the presence of a carrier-mediated reabsorption which apparently was no longer operating in the decompensated patients. Discriminant analysis showed that renal NMN clearance, and NMN-to-creatinine and NMN-to-inulin clearance ratios could all distinguish between the three study groups, with sensitivities and specificities equal or greater than 90%. CONCLUSIONS: Contrary to previous proposals, NMN is not a probe of general validity for renal tubular secretion. In particular, due to an imbalance between secretion and reabsorption, its renal clearance in liver cirrhosis cannot be used to determine the degree of tubular secretion of which an individual is capable. However, renal NMN clearance appears to be a very sensitive marker of the severity of liver dysfunction in cirrhosis. The potentialities of this renal parameter as a diagnostic and prognostic test in liver cirrhosis deserve further study. Copyright 2000 S. Karger AG, Basel
机译:背景/目的:数据表明,即使在没有临床上明显的肾功能不全的情况下,肝硬化也存在肾小管分泌受损。为了解决这个问题,我们在健康受试者和严重肝炎但肾小球滤过率正常的健康受试者和肝硬化患者中评估了N(1)-甲基烟酰胺(NMN)的肾脏清除率,NMN是肾脏分泌功能的标志物。方法:在14名正常受试者和两组年龄匹配的肝硬化患者(10例儿童A和10例儿童C)中测量了内源性NNN,菊粉和肌酐的肾脏清除率。在6名受试者中,每组2名,还研究了口服烟酰胺后NMN清除率的浓度依赖性。结果:与预期相反,肝硬化患者的肾脏NMN清除率与肝病的严重程度有关(r = 0.83,Pugh评分; p <0.001)。儿童A和儿童C肝硬化患者的NMN与菊粉清除率分别从控制值2.2 +/-(SD)增加到3.1 +/- 0.2和5.2 +/- 0.9(所有比较的p <0.001 ),表明后者患者的血浆中NMN已完全清除。一致地,对肾脏NMN清除浓度依赖性的分析显示,存在载体介导的重吸收,在失代偿患者中显然不再起作用。判别分析表明,肾脏NMN清除率,NMN与肌酐的清除率以及NMN与胰岛素的清除率都可以区分这三个研究组,其敏感性和特异性均等于或大于90%。结论:与以前的建议相反,NMN并不是肾小管分泌物一般有效性的探针。特别地,由于分泌和再吸收之间的不平衡,其在肝硬化中的肾清除率不能用于确定个体能够进行的肾小管分泌的程度。但是,肾NMN清除似乎是肝硬化肝功能障碍严重程度的非常敏感的标志。该肾参数作为肝硬化诊断和预后测试的潜力值得进一步研究。版权所有2000 S. Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号